Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Sindelfingen

6 clinical trials in Sindelfingen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Sindelfingen at a glance
6
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Sindelfingen

Open in trial search

Chronic lymphocytic leukaemia

Recruiting

Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne

Triple negative breast cancer+4

Recruiting

Study Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:WSG Women's Cancer Study Group GmbH

Breast cancer+4

Not recruiting

Study Comparing Ribociclib and Endocrine Therapy to Chemotherapy for Patients with Intermediate-Risk HR+/HER2- Early Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne

Acute myeloid leukaemia

Not recruiting

Study of Venetoclax and Azacitidine for Adults 18+ with Acute Myeloid Leukemia Not Eligible for Standard Therapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Universitaet Leipzig

Acute myeloid leukaemia

Not recruiting

Study of Magrolimab and Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Stem Cell Transplantation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaet Leipzig

Other cities in Germany

The busiest research cities in the country

All 513 cities in Germany

Clinical research in Sindelfingen

What the registry says about research in the country

01 Lymphoma Research

Innovative research focusing on Advanced Stage Hodgkin Lymphoma, evaluating new treatment combinations to reduce toxicity while maintaining therapeutic effectiveness.

  • Treatment-related morbidity assessment
  • Progression-free survival studies
  • Radiotherapy optimization

Novel therapeutic approaches combining established protocols with targeted interventions.

02 Chronic Lymphocytic Leukemia Studies

Advanced research targeting high-risk CLL patients, investigating triple-combination therapies for improved treatment outcomes.

  • Genetic mutation analysis
  • Novel drug combinations
  • Treatment resistance studies

Focusing on personalized treatment approaches for patients with specific genetic markers.

03 Acute Myeloid Leukemia Research

Comprehensive studies on Acute Myeloid Leukemia and high-risk myelodysplastic neoplasia, exploring innovative treatment combinations.

  • Intensive chemotherapy protocols
  • Stem cell transplantation research
  • Alternative treatment strategies

Investigating new therapeutic options for patients ineligible for standard treatments.

Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.